Sponsor or institution
Clinical trials and research at Instituto do Cancer do Estado de São Paulo
As of November 12, 2026, Find a Trial lists 11 clinical trials run by Instituto do Cancer do Estado de São Paulo that are recruiting, in Brazil. By phase: Phase 2 (5), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 1Country
Newest trials
All recruiting trials (11)
-
Ice water plus NSAIDs to prevent post-ERCP pancreatitis
This study tests whether adding ice-cold water irrigation to the standard NSAID prevention can further reduce post-ERCP pancreatitis in adults.
-
Docetaxel plus 177Lu-PSMA-I&T in first-line mCRPC
This early-phase study tests if giving docetaxel with a fixed dose of 177Lu-PSMA-I&T is safe and tolerable for men with metastatic castration-resistant prostate cancer who have not yet had chemotherapy for this stage.
-
AI-assisted colonoscopy to find and classify colorectal lesions
This trial tries to see if using AI during routine colonoscopy helps doctors find more adenomas and better classify colorectal lesions in adults.
-
Combining oral arsenic and ATRA for treating newly diagnosed acute promyelocytic leukemia
This study is testing if a new treatment combining oral arsenic and ATRA can help newly diagnosed patients with acute promyelocytic leukemia live longer and feel better, especially those at high risk.
-
Blood ctDNA testing to guide follow-up and treatment for HPV-related cervical and anal canal cancers.
This study will test whether regular blood tests for HPV ctDNA can guide follow-up and whether giving pembrolizumab after radiotherapy helps people with HPV-related cervical or anal canal cancer who still have positive ctDNA.
-
Comparing two solutions for endoscopic removal of early esophageal cancer
This study is testing two different solutions to see which one works better for safely removing early esophageal cancer in patients.
-
Comparing two types of esophageal stents for treating swallowing difficulties in cancer patients
This study is testing whether fully covered or partially covered esophageal stents can help cancer patients with swallowing difficulties feel better.
-
Bortezomib treatment for relapsed or refractory acute lymphoblastic leukemia
This study is testing if a new treatment using bortezomib can help adults with hard-to-treat acute lymphoblastic leukemia feel better and prepare for a stem cell transplant.
-
Treatment of adult acute lymphoblastic leukemia with a pediatric regimen in Brazil
This study is testing a children's leukemia treatment plan to see if it can help adults in Brazil with a specific type of leukemia live longer and have fewer health problems.
-
Local therapy for hormone receptor-positive oligometastatic breast cancer
This study tests if adding local treatments like surgery or radiation to standard therapy can help people with a specific type of breast cancer live longer without their cancer getting worse.
-
Preoperative chemotherapy for locally advanced gastric cancer
This study is testing if a specific chemotherapy treatment can help patients with locally advanced stomach cancer before they have surgery to remove the tumor.
Quick answers
How many clinical trials run by Instituto do Cancer do Estado de São Paulo are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Brazil. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.